Cargando…

Intravitreal injections of anti-VEGF agents during COVID-19 pandemic: clinical audit from Tanta University Hospital

BACKGROUND: The aims of this study were to provide real-life data about the effect of COVID-19 pandemic on the practice of anti-VEGF injections and to evaluate the safety of the modifications in the injection protocol imposed during the ongoing pandemic on the anatomical and functional outcome of pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moussa, Magdy, Elshorbagy, Muhammed Sameh, Emarah, Ayman, Gaber, Raouf, Moussa, Omar M., El-Bradey, Mohamed, Alagorie, Ahmed Roshdy, Sorour, Osama A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2021
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818066/ https://www.ncbi.nlm.nih.gov/pubmed/33475906 http://dx.doi.org/10.1007/s10792-021-01719-y

Ejemplares similares

Evaluation of Urgent Retinal Practice and Safety Measures for Physicians and Patients During COVID-19 Pandemic
por: Alagorie, Ahmed Roshdy, et al.
Publicado: (2022)

Tantas veces Pedro /
por: Bryce Echenique, Alfredo, 1939-
Publicado: (1989)

Tantas veces enero /
por: Barjau, Luis
Publicado: (1993)

De las tantas voces /
por: Pérez Sepúlveda, Ofelia
Publicado: (2006)

Profile and outcomes of acute poisoning in the toxicology treatment and control center at Tanta University Hospital, Egypt
por: Rageh, Omar El-Sayed, et al.
Publicado: (2023)

A customized regimen of intravitreal aflibercept for the treatment of choroidal neovascularization secondary to different chorioretinal diseases
por: Moussa, Magdy, et al.
Publicado: (2023)

Inflammatory Complications of Intravitreal Anti-VEGF Injections
por: Cox, Jacob T., et al.
Publicado: (2021)

Hypotony Maculopathy Related to Anti-VEGF Intravitreal Injection
por: Lima-Fontes, Mário, et al.
Publicado: (2022)

Clinical and angiographic characteristics of patients with STEMI and confirmed diagnosis of COVID-19: an experience of Tanta University Hospital
por: Alaarag, Ahmed, et al.
Publicado: (2020)

Como tanta gente que anda por ahí /
por: Battista, Vicente
Publicado: (1975)

Current Evidence for the Prevention of Endophthalmitis in Anti-VEGF Intravitreal Injections
por: Lau, P. ET., et al.
Publicado: (2018)

Customized Slab-Segmentation Method for Projection-Artifact Elimination in Best Vitelliform Macular Dystrophy: A Swept-Source Optical Coherence Tomography Angiography Study
por: Moussa, Magdy, et al.
Publicado: (2021)

Bullying among undergraduate medical students at Tanta University, Egypt: a cross-sectional study
por: Elghazally, Noha Mohammed, et al.
Publicado: (2020)

Estimation of the need for bilateral intravitreal anti-VEGF injections in clinical practice
por: Giocanti-Auregan, Audrey, et al.
Publicado: (2016)

Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic
por: Korobelnik, Jean-François, et al.
Publicado: (2020)

The Association of Intravitreal Anti-VEGF Injections With Kidney Function in Diabetic Retinopathy
por: Bunge, Casey C., et al.
Publicado: (2023)

Management of Choroidal Neovascularization Associated with Optic Disc Melanocytoma with Intravitreal Aflibercept: A Case Report and Review of the Literature
por: Hamza, Hany S., et al.
Publicado: (2019)

Incidence and Risk Factors for Retinopathy of Prematurity (ROP) in Biggest Neonatal Intensive Care Unit in Itay Elbaroud City, Behera Province, Egypt
por: Gaber, Raouf, et al.
Publicado: (2021)

Intravitreally Injected Anti-VEGF Antibody Reduces Brown Fat in Neonatal Mice
por: Jo, Dong Hyun, et al.
Publicado: (2015)

Retinal reperfusion in diabetic retinopathy following treatment with anti-VEGF intravitreal injections
por: Levin, Ariana M, et al.
Publicado: (2017)

Concentrations of VEGF and PlGF Decrease in Eyes After Intravitreal Conbercept Injection
por: Zhou, Jun, et al.
Publicado: (2018)

Intravitreal Injection of Anti-VEGF Antibody Induces Glomerular Endothelial Cells Injury
por: Touzani, F., et al.
Publicado: (2019)

Use of Artificial Tears in Patients Undergoing Treatment with Anti-VEGF Intravitreal Injections
por: Pastor-Pascual, Francisco, et al.
Publicado: (2022)

Prevalence and Associated Factors of Eating Disorders in Weight Management Centers in Tanta, Egypt
por: Eladawi, Noha, et al.
Publicado: (2018)

Observation of total VEGF level in hyperglycemic mouse eyes after intravitreal injection of the novel anti-VEGF drug conbercept
por: Du, Liping, et al.
Publicado: (2015)

Incidence of endophthalmitis after intravitreal injection of an anti-VEGF agent with or without topical antibiotics
por: Morioka, Masakazu, et al.
Publicado: (2020)

Intravitreal vascular endothelial growth factor (VEGF) inhibitor injection in patient during pregnancy
por: Kianersi, Farzan, et al.
Publicado: (2021)

Potential bias of preoperative intravitreal anti-VEGF injection for complications of proliferative diabetic retinopathy
por: Takayama, Kei, et al.
Publicado: (2021)

Hydrophilic Lens Opacification after Intravitreal Anti-VEGF Injections: A Case Series
por: Wahab, Charbel, et al.
Publicado: (2022)

Acute macular neuroretinopathy associated with intravitreal anti-VEGF injection: A case report
por: Radwan, Loubna M., et al.
Publicado: (2022)

Bacterial endophthalmitis following anti-VEGF intravitreal injections: a retrospective case series
por: Bergamo, Vinicius Campos, et al.
Publicado: (2023)

Health disorders and safety measures among workers in Tanta Flax and Oil Company, Egypt
por: El-Feky, Asmaa Ali, et al.
Publicado: (2020)

Multimodal imaging of macular telangiectasia type 2 in a pediatric patient()
por: Moussa, Magdy, et al.
Publicado: (2021)

Concomitant bilateral intravitreal anti-VEGF injections for the treatment of exudative age-related macular degeneration
por: Davis, R Prince, et al.
Publicado: (2010)

Comparison of Systemic Adverse Events Associated with Intravitreal Anti-VEGF Injection: Ranibizumab versus Bevacizumab
por: Hwang, Duck Jin, et al.
Publicado: (2012)

Incidence of ocular hypertension after intravitreal injection of anti-VEGF agents in the treatment of neovascular AMD
por: Moraru, Andreea, et al.
Publicado: (2017)

Intraocular Pressure Elevation Following Intravitreal Anti-VEGF Injections: Short- and Long-term Considerations
por: Levin, Ariana M., et al.
Publicado: (2021)

Anti-VEGF intravitreal injections in the era of COVID-19: responding to different levels of epidemic pressure
por: Korobelnik, Jean-François, et al.
Publicado: (2021)

Clinical Features Associated with Acute Elevated Intraocular Pressure After Intravitreal Anti-VEGF Injections
por: LoBue, Stephen A, et al.
Publicado: (2023)

Review on Recent Trials Evaluating the Effect of Intravitreal Injections of Anti-VEGF Agents on the Macular Perfusion of Diabetic Patients with Diabetic Macular Edema
por: Elnahry, Ayman G., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lo126vmabqnvp7n6qhv2k5vmkr